Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan, Christoph Weinlinger, Amanda Tufman, Aurélie Swalduz, Kristina Lamberg, Sayed M. S. Hashemi, Florian Huemer, Anders Vikström, Martin Wermke, Gudrun Absenger, Alfredo Addeo, Shantanu Banerji, Antonio Calles, Stephen Clarke, Massimo Di Maio, Alice Durand, Michaël Duruisseaux, Malinda Itchins, Okko-Sakari Kääränien, Florian Krenn, Eckart Laack, Adrianus Johannes de Langen, Katja Mohorcic, Georg Pall, Antonio Passaro, Gerald Prager, Achim Rittmeyer, Jeffrey Rothenstein, Michael Schumacher, Ewald Wöll, Arschang Valipour

Open source

DOI: 10.1177/17588359211019675
Published: 2021-01
Container: Therapeutic Advances in Medical Oncology
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17588359211019675,
  title = {Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program},
  author = {Oliver Illini and Maximilian Johannes Hochmair and Hannah Fabikan and Christoph Weinlinger and Amanda Tufman and Aurélie Swalduz and Kristina Lamberg and Sayed M. S. Hashemi and Florian Huemer and Anders Vikström and Martin Wermke and Gudrun Absenger and Alfredo Addeo and Shantanu Banerji and Antonio Calles and Stephen Clarke and Massimo Di Maio and Alice Durand and Michaël Duruisseaux and Malinda Itchins and Okko-Sakari Kääränien and Florian Krenn and Eckart Laack and Adrianus Johannes de Langen and Katja Mohorcic and Georg Pall and Antonio Passaro and Gerald Prager and Achim Rittmeyer and Jeffrey Rothenstein and Michael Schumacher and Ewald Wöll and Arschang Valipour},
  year = {2021},
  journal = {Therapeutic Advances in Medical Oncology},
  doi = {10.1177/17588359211019675},
  url = {https://doi.org/10.1177/17588359211019675}
}

RIS

TY  - JOUR
TI  - Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
AU  - Oliver Illini
AU  - Maximilian Johannes Hochmair
AU  - Hannah Fabikan
AU  - Christoph Weinlinger
AU  - Amanda Tufman
AU  - Aurélie Swalduz
AU  - Kristina Lamberg
AU  - Sayed M. S. Hashemi
AU  - Florian Huemer
AU  - Anders Vikström
AU  - Martin Wermke
AU  - Gudrun Absenger
AU  - Alfredo Addeo
AU  - Shantanu Banerji
AU  - Antonio Calles
AU  - Stephen Clarke
AU  - Massimo Di Maio
AU  - Alice Durand
AU  - Michaël Duruisseaux
AU  - Malinda Itchins
AU  - Okko-Sakari Kääränien
AU  - Florian Krenn
AU  - Eckart Laack
AU  - Adrianus Johannes de Langen
AU  - Katja Mohorcic
AU  - Georg Pall
AU  - Antonio Passaro
AU  - Gerald Prager
AU  - Achim Rittmeyer
AU  - Jeffrey Rothenstein
AU  - Michael Schumacher
AU  - Ewald Wöll
AU  - Arschang Valipour
PY  - 2021
JO  - Therapeutic Advances in Medical Oncology
DO  - 10.1177/17588359211019675
UR  - https://doi.org/10.1177/17588359211019675
ER  -

APA

Illini, O., Hochmair, M. J., Fabikan, H., Weinlinger, C., Tufman, A., Swalduz, A., Lamberg, K., Hashemi, S. M. S., Huemer, F., Vikström, A., Wermke, M., Absenger, G., Addeo, A., Banerji, S., Calles, A., Clarke, S., Maio, M. D., Durand, A., Duruisseaux, M., Itchins, M., Kääränien, O., Krenn, F., Laack, E., Langen, A. J. D., Mohorcic, K., Pall, G., Passaro, A., Prager, G., Rittmeyer, A., Rothenstein, J., Schumacher, M., Wöll, E., & Valipour, A. (2021). Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/17588359211019675

Source records

crossref · retrieved 2026-09-26T08:35:19.247Z